Phase 2 trial shows chikungunya vaccine to be safe, immunogenic
5 NOV - Reisinger et al.
MV-CHIK showed excellent safety and tolerability and good immunogenicity, independent of pre-existing immunity against the vector. MV-CHIK is a promising candidate vaccine for the prevention of chikungunya fever, an emerging disease of global concern.
Community-based cohort studies may hold the key to tackling dengue infections
5 NOV - The monsoons in India bring with them a much-awaited relief from the summer's heat, and a host of headline-catching infectious diseases. In a country with a population of over 100 million, managing contagious diseases that burden the economy and public health is a challenge.
Zika Biomarkers Could Lead to Prenatal Diagnostic
2 NOV - Discovery that could lead to screening tests and a better understanding about how the infection leads to fetal abnormalities. Findings from the new study were published today in the Journal of Clinical Investigation Insight.
Health insurance and patient satisfaction: Evidence from the poorest regions of Vietnam
2 NOV - Nga Le et al.,
Even though health insurance is expanding rapidly in Vietnam, its coverage is not effective. There remain inefficiencies in the healthcare system with quality concerns, especially at primary care and in remote areas. However, very little is known about how health insurance is valued by people and whether health insurance coverage can translate into quality healthcare. This paper investigates the relationship between health insurance and patient satisfaction with medical care in the poorest regions of Vietnam. The authors use multi-level models for ordinal responses on a cross-sectional dataset of the poorest regions of Vietnam in 2012. They find that it is not health insurance coverage per se but the financial coverage that matters to improve patient satisfaction with medical care. Patient satisfaction depends on the breadth and depth of insurance coverage (i.e. services and medicines covered, co-payment rate for each service) and the ability to use health insurance to reduce medical costs via the co-payment mechanism.
Influenza H5/H7 Virus Vaccination in Poultry and Reduction of Zoonotic Infections, Guangdong Province, China, 2017–18
Ahead of print - Wu et al.
We compared the detection frequency of avian influenza H7 subtypes at live poultry markets in Guangdong Province, China, before and after the introduction of a bivalent H5/H7 vaccine in poultry. The vaccine was associated with a 92% reduction in H7 positivity rates among poultry and a 98% reduction in human H7N9 cases.
Study notes high MCR rates in healthy villagers in Vietnam
31 OCT - Via CIDRAP subscription required
More than 80% of Escherichia coli–positive stool specimens collected from healthy people in a village in Vietnam contained the colistin-resistance MCR gene, according to a research letter today in the Journal of Antimicrobial Chemotherapy.
Drones to be trialed for vaccine transport in Vanuatu
30 OCT - The Vanuatu government has contracted two companies to trial drones that could one day fly vaccines to children in remote areas. The government has partnered with the UN children's agency UNICEF to select an Australian and a German company for the trial in January.
Four nations report total of 9 new polio cases
30 OCT- Three cases of circulating vaccine-derived poliovirus type 1 (cVDPV1) were reported this week from Jiwaka province, Gulf province and Southern Highlands province, with dates of onset of paralysis on 20 August, 29 August and 8 September , respectively.
China reports new African swine fever in Hunan province
29 OCT - China’s agricultural ministry reported on Sunday a new outbreak of African swine fever in Changde city of central Hunan province, where 99 pigs were killed and 106 were sick.
MERS experts team being established for rapid deployment
26 OCT - This week, 60 high-level public health and MERS practitioners, researchers, and experts met in Abu Dhabi to establish a pool of experts that can be deployed rapidly during any future outbreaks, as well as share and discuss the latest evidence, best practices, and lessons learned on MERS.